Response to Letter Regarding Article, “Rosiglitazone and Outcomes for Patients With Diabetes Mellitus and Coronary Artery Disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial”
Circulation | April 21, 2014 | Volume: 129 | Issue: 16 | Pages: No page available
10.1161/circulationaha.113.008033
| PMID 24753557